Cilcare and CBSET at ARO 2026: Advancing translational and clinical auditory research

Cilcare is taking part in the 2026 ARO MidWinter Meeting in Puerto Rico, together with its partner CBSET, one of the leading international gatherings dedicated to hearing and balance research.

This joint presence reflects the complementary expertise of Cilcare and CBSET, with scientific contributions spanning preclinical, translational, and clinical auditory research. Throughout the meeting, our teams engage with the international auditory research community to share recent advances and exchange perspectives on the future of the field.

Scientific contributions at ARO 2026

  • PIHL Satellite Symposium – Translational models in NIHL, synaptopathy & inflammation
    Gaëlle Naert – February 6, 1:00 PM
  • Symposium (in vitro models) – Cochlear explant as a reference ex vivo model and a platform for developing in vitro systems
    Marianne Aincy – February 8, 8:00 AM
  • Podium Presentation – DIAMANT clinical results
    Speech-in-Noise as a biomarker for peripheral auditory neuropathy in metabolic disorders: proof of concept in patients with uncontrolled type 2 diabetes
    Jérôme Nevoux – February 7, 2:30 PM

In addition, nine scientific posters presented by Cilcare–CBSET teams highlight ongoing work in inner ear biology and translational science.

Meet us at Booth #18

The Cilcare and CBSET teams are available throughout the meeting at Booth #18 to discuss hearing research and development programs, translational strategies, and collaborative opportunities.

ARO 2026 is a key moment for scientific exchange, and we look forward to connecting with partners, colleagues, and the broader auditory research community.

Share the Post: